---
figid: PMC10523227__WJD-14-1349-g004
pmcid: PMC10523227
image_filename: WJD-14-1349-g004.jpg
figure_link: /pmc/articles/PMC10523227/figure/F4/
number: Figure 4
figure_title: ''
caption: 'Genipin reduces retinal oxidant stress, glucose metabolism, and inflammation
  in streptozotocin-induced mice. A: Blood sugar levels of mice induced with streptozotocin
  (STZ) for 2 wk and 4 wk; B: Hematoxylin and eosin staining of STZ mouse retina;
  C: Retinal thickness in different eyes of STZ mice; D: Inflammatory factor expression
  measured by Western blot; E and F: Reactive oxygen species and 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)
  amino]-2-deoxy-d-glucose levels in STZ mice; G and F: RAGE, SCG3, and vascular endothelial
  growth factor expression in STZ mice. IL: Interleukin; TNF: Tumor necrosis factor-alpha;
  NLRP3: Nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing
  3; VEGF: Vascular endothelial growth factor; ROS: Reactive oxygen species; MMP:
  Mitochondrial membrane potential; 2-NBDG: 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)
  amino]-2-deoxy-d-glucose; OS: Left eye, without genipin-treated; OD: Right eye,
  genipin-treated; GCL: Ganglion cell layer; INL: Inner nuclear layer; ONL: Outer
  nuclear layer.'
article_title: Genipin relieves diabetic retinopathy by down-regulation of advanced
  glycation end products via the mitochondrial metabolism related signaling pathway.
citation: Ke-Xin Sun, et al. World J Diabetes. 2023 Sep 15;14(9):1349-1368.
year: '2023'

doi: 10.4239/wjd.v14.i9.1349
journal_title: World Journal of Diabetes
journal_nlm_ta: World J Diabetes
publisher_name: Baishideng Publishing Group Inc

keywords:
- Genipin
- Human retinal microvascular endothelial cells
- Angiogenesis
- Vascularization
- Secretogranin III
- Diabetic retinopathy

---
